OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
Ana C. Puhl, Thomas R. Lane, Fabio Urbina, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 8
Ana C. Puhl, Thomas R. Lane, Fabio Urbina, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 8
Showing 8 citing articles:
Project NextGen: Developing the Next Generation of Coronavirus Disease 2019 (COVID-19) Vaccines and Therapeutics to Respond to the Present and Prepare for the Future
Kimberly A. Hofmeyer, Christy L. Ventura, Kimberly L. Armstrong, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 115-121
Open Access | Times Cited: 4
Kimberly A. Hofmeyer, Christy L. Ventura, Kimberly L. Armstrong, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 115-121
Open Access | Times Cited: 4
In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays
Nicholas van Eijk, Luna C. Schmacke, Torsten Steinmetzer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115761-115761
Open Access | Times Cited: 5
Nicholas van Eijk, Luna C. Schmacke, Torsten Steinmetzer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115761-115761
Open Access | Times Cited: 5
Learning from COVID-19: How drug hunters can prepare for the next pandemic
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses
Amrita Saha, Badri Narayan Acharya, Manmohan Parida, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2194-2194
Open Access | Times Cited: 2
Amrita Saha, Badri Narayan Acharya, Manmohan Parida, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2194-2194
Open Access | Times Cited: 2
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules
Álvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1448-1448
Open Access | Times Cited: 3
Álvaro Simba-Lahuasi, Ángel Cantero-Camacho, Romel Rosales, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1448-1448
Open Access | Times Cited: 3
The Antiviral Effects of Heat-Killed Lactococcus lactis Strain Plasma Against Dengue, Chikungunya, and Zika Viruses in Humans by Upregulating the IFN-α Signaling Pathway
Zhao Xuan Low, Osamu Kanauchi, Vunjia Tiong, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2304-2304
Open Access
Zhao Xuan Low, Osamu Kanauchi, Vunjia Tiong, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2304-2304
Open Access
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model
Meehyun Ko, Jun Young Lee, Young Sup Shin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 1
Meehyun Ko, Jun Young Lee, Young Sup Shin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 1
Engineered Therapeutic Antibody Against SARS-CoV-2
Monrat Chulanetra
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 4, pp. 222-235
Closed Access
Monrat Chulanetra
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 4, pp. 222-235
Closed Access
